Ryan Benjamin J, Van Pelt Douglas W, Guth Lisa M, Ludzki Alison C, Gioscia-Ryan Rachel A, Ahn Chiwoon, Foug Katherine L, Horowitz Jeffrey F
Substrate Metabolism Laboratory, School of Kinesiology, University of Michigan, Ann Arbor, MI, USA.
Exp Physiol. 2018 Nov;103(11):1443-1447. doi: 10.1113/EP087283. Epub 2018 Oct 8.
What is the central question of this study? Do obese women with relatively high whole-body iron stores exhibit elevated in vivo rates of fatty acid (FA) release from adipose tissue compared with a well-matched cohort of obese women with relatively low iron stores? What is the main finding and its importance? Obese women with high plasma [ferritin] (a marker of whole-body iron stores) had greater FA mobilization, lipolytic activation in adipose tissue and insulin resistance (IR) compared with obese women with lower plasma [ferritin]. Given that elevated FA mobilization is intimately linked with the development of IR, these findings suggest that elevated iron stores might contribute to IR in obesity by increasing systemic FA availability.
High rates of fatty acid (FA) mobilization from adipose tissue are associated with insulin resistance (IR) in obesity. In vitro evidence suggests that iron stimulates lipolysis in adipocytes, but whether iron is related to in vivo FA mobilization is unknown. We hypothesized that plasma ferritin concentration ([ferritin]), a marker of body iron stores, would be positively associated with FA mobilization. We measured [ferritin], the rate of appearance of FA in the systemic circulation (FA Ra; stable isotope dilution), key adipose tissue lipolytic proteins and IR (hyperinsulinaemic-euglycaemic clamp) in 20 obese, premenopausal women. [Ferritin] was correlated with FA Ra (r = 0.65; P = 0.002) and IR (r = 0.57; P = 0.008); these relationships remained significant after controlling for body mass index and plasma [C-reactive protein] (a marker of systemic inflammation) in multiple regression analyses. We then stratified subjects into tertiles based on [ferritin] to compare subjects with 'High-ferritin' versus 'Low-ferritin'. Plasma [hepcidin] was more than fivefold greater (P < 0.05) in the High-ferritin versus Low-ferritin group, but there was no difference in plasma [C-reactive protein] between groups, indicating that the large difference in plasma [ferritin] reflects a difference in iron stores, not systemic inflammation. We found that FA Ra, adipose protein abundance of hormone-sensitive lipase and adipose triglyceride lipase, and IR were significantly greater in subjects with High-ferritin versus Low-ferritin (all P < 0.05). These data provide the first evidence linking iron and in vivo FA mobilization and suggest that elevated iron stores might contribute to IR in obesity by increasing systemic FA availability.
本研究的核心问题是什么?与一组铁储备相对较低且匹配良好的肥胖女性相比,全身铁储备相对较高的肥胖女性体内脂肪组织脂肪酸(FA)释放率是否升高?主要发现及其重要性是什么?与血浆[铁蛋白](全身铁储备的标志物)水平较低的肥胖女性相比,血浆[铁蛋白]水平较高的肥胖女性具有更强的FA动员能力、脂肪组织脂解激活能力和胰岛素抵抗(IR)。鉴于FA动员增加与IR的发展密切相关,这些发现表明铁储备升高可能通过增加全身FA的可利用性而导致肥胖中的IR。
肥胖中脂肪组织脂肪酸(FA)的高动员率与胰岛素抵抗(IR)相关。体外证据表明铁可刺激脂肪细胞的脂解作用,但铁是否与体内FA动员有关尚不清楚。我们假设血浆铁蛋白浓度([铁蛋白]),即身体铁储备的标志物,将与FA动员呈正相关。我们测量了20名肥胖的绝经前女性的[铁蛋白]、FA在体循环中的出现率(FA Ra;稳定同位素稀释法)、关键脂肪组织脂解蛋白和IR(高胰岛素-正常血糖钳夹法)。[铁蛋白]与FA Ra(r = 0.65;P = 0.002)和IR(r = 0.57;P = 0.008)相关;在多元回归分析中,在控制体重指数和血浆[C反应蛋白](全身炎症的标志物)后,这些关系仍然显著。然后我们根据[铁蛋白]将受试者分为三分位数,以比较“高铁蛋白”组和“低铁蛋白”组的受试者。高铁蛋白组的血浆[铁调素]比低铁蛋白组高五倍多(P < 0.05),但两组间血浆[C反应蛋白]无差异,这表明血浆[铁蛋白]的巨大差异反映的是铁储备的差异,而非全身炎症。我们发现,与低铁蛋白组相比,高铁蛋白组的受试者FA Ra、激素敏感性脂肪酶和脂肪甘油三酯脂肪酶的脂肪蛋白丰度以及IR均显著更高(均P < 0.05)。这些数据首次提供了铁与体内FA动员之间的联系证据,并表明铁储备升高可能通过增加全身FA的可利用性而导致肥胖中的IR。